Literature DB >> 270728

Enzymatic formation of glutathione-citryl thioester by a mitochondrial system and its inhibition by (-)erythrofluorocitrate.

E Kun, E Kirsten, M L Sharma.   

Abstract

A soluble extract of the mitochondrial compartment composed of the inner membrane and matrix catalyzes the enzymatic synthesis and hydrolysis of the 1:1 adduct of citric acid and glutathione. The adduct was identified as the thioester by isolation with single and double isotope labeling ([(14)C]citric acid and [(35)S]glutathione) and by conversion to the monohydroxamate of citric acid and comparison with the synthetic product by thin layer chromatography and high voltage electrophoresis. The enzymatic formation of the thioester (pH optimum 7.39 at 30 degrees ) requires oxidized glutathione and citrate; both substrates exhibit a Michaelis-Menten kinetics. During the enzymatic reaction equimolar quantities of thioester and glutathione sulfinic acid are formed. After gel filtration or salt fractionation the enzyme system requires Mn(2+) (or Mg(2+), which is less effective) for maximal activity. When extracts of mitoplast are tested, the time course of reaction is biphasic due to the rapid synthesis of the product by the thioester-forming system (molecular weight 171,000) followed by its decay by the hydrolase (molecular weight 71,000). The two systems were separated by molecular filtration on Sephadex G-200 and by precipitation with (NH(4))(2)SO(4). The thioester-forming system is inhibited by preincubation with 0.5 mM mersalyl. Other inhibitors are 1,2,3-propane tricarboxylic acid, 10 mM Ca(2+), 200 mM K(+), and the free radical trapping agent, phenazine methosulfate. The citrate-glutathione thioester formation is irreversibly and specifically inhibited by (-)erythrofluorocitrate (50% inhibition at 25 pmol of added fluorocitrate per mg of protein), which forms a trichloroacetic acid-stable adduct with the enzyme protein (at 50% inhibition, 0.8 pmol is bound to 1 mg of protein). Synthesis of malyl-glutathione thioester by inner membrane vesicles is selectively inhibited by (-)erythrofluoromalate.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 270728      PMCID: PMC432073          DOI: 10.1073/pnas.74.11.4942

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  STUDIES ON SPECIFIC ENZYME INHIBITORS. VI. CHARACTERIZATION AND MECHANISM OF ACTION OF THE ENZYME-INHIBITORY ISOMER OF MONOFLUOROCITRATE.

Authors:  D W FANSHIER; L K GOTTWALD; E KUN
Journal:  J Biol Chem       Date:  1964-02       Impact factor: 5.157

2.  [Evaluation of the citric acid carrier in the mitochondrial membrane. II].

Authors:  I Stipani; G Prezioso; G Genchi; F Palmieri
Journal:  Boll Soc Ital Biol Sper       Date:  1976-08-30

Review 3.  The metabolic significance of anion transport in mitochondria.

Authors:  A J Meijer; K Van Dam
Journal:  Biochim Biophys Acta       Date:  1974-12-30

4.  The effects of 2-ethylcitrate and tricarballylate on citrate transport in rat liver mitochondria and fatty acid synthesis in rat white adipose tissue.

Authors:  B H Robinson; G R Williams; M L Halperin; C C Leznoff
Journal:  Eur J Biochem       Date:  1970-08

5.  Inhibition of liver aconitase isozymes by (-)-erythro-fluorocitrate.

Authors:  R Z Eanes; E Kun
Journal:  Mol Pharmacol       Date:  1974-01       Impact factor: 4.436

6.  Kinetic study of glutamate transport in rat liver mitochondria.

Authors:  J Meyer; P M Vignais
Journal:  Biochim Biophys Acta       Date:  1973-12-14

7.  Studies with specific enzyme inhibitors. XIV. The effects of enzymatically synthesized (-)-erythro-fluoromalic acid on malate dehydrogenase and on anion carriers of liver mitochondria.

Authors:  D N Skilleter; R J Dummel; E Kun
Journal:  Mol Pharmacol       Date:  1972-03       Impact factor: 4.436

8.  Preparation and assay of glutathione thiol esters. Survey of human liver glutathione thiol esterases.

Authors:  L Uotila
Journal:  Biochemistry       Date:  1973-09-25       Impact factor: 3.162

9.  Fluorocitrate inhibition of aconitase: relative configuration of inhibitory isomer by x-ray crystallography.

Authors:  H L Carrell; J P Glusker; J J Villafranca; A S Mildvan; R J Dummel; E Kun
Journal:  Science       Date:  1970-12-25       Impact factor: 47.728

10.  Covalent modification of proteins by metabolites of NAD+.

Authors:  E Kun; A C Chang; M L Sharma; A M Ferro; D Nitecki
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

View more
  5 in total

Review 1.  Fluoroacetate and fluorocitrate: mechanism of action.

Authors:  D D Clarke
Journal:  Neurochem Res       Date:  1991-09       Impact factor: 3.996

2.  A new selection method for isolating mutants defective in acetate utilisation in Aspergillus nidulans.

Authors:  H M Sealy-Lewis
Journal:  Curr Genet       Date:  1994-01       Impact factor: 3.886

3.  The reaction of fluorocitrate with aconitase and the crystal structure of the enzyme-inhibitor complex.

Authors:  H Lauble; M C Kennedy; M H Emptage; H Beinert; C D Stout
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

4.  The reduction of diamide by rat liver mitochondria and the role of glutathione.

Authors:  P C Jocelyn
Journal:  Biochem J       Date:  1978-12-15       Impact factor: 3.857

5.  Promiscuous Defluorinating Enoyl-CoA Hydratases/Hydrolases Allow for Complete Anaerobic Degradation of 2-Fluorobenzoate.

Authors:  Oliver Tiedt; Mario Mergelsberg; Wolfgang Eisenreich; Matthias Boll
Journal:  Front Microbiol       Date:  2017-12-21       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.